浅谈冠状动脉粥样硬化性心脏病合理用药
摘要
冠状动脉粥样硬化性心脏病（冠心病）是指冠状动脉病变导致的心肌缺血、缺氧而引起的心脏病，亦称缺血性心脏病。此病在我国发病率较高，药物治疗的目的是改善冠状动脉的供血和减轻心肌的耗氧。本文对冠状动脉粥样硬化性心脏病合理用药进行了探讨。
二级参考文献48
-
1Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.
-
2Ryden L, Standl E, Bartnic M, et al. Guideline on diabetes, prediabetes and cardiovascular disease:executive summary. The Task Force on Diabetes and Cardiovascular Disease of European Society of Cardiology (ESC) and of the Euopean Association for the Study of Diabetes(EASD). Eur Heart J,2007,28( 1 ) :88-136.
-
3Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.J Am Coll Cardiol,1999,34(3) :912-948.
-
4Campeau L. Letter: Grading of angina pectoris. Circulation 1976 :54(3) :522-523.
-
5O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000,36(1) :326-340.
-
6Gibbons Pal, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-sunanary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 2003,41 ( 1 ) : 159-168.
-
7Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004,110(10) :1245-1250.
-
8Girman CJ, Rhodes T, Mercuri M,et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherescleresis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol,2004,93 ( 2 ) : 136-141.
-
9Kjekshus JK, Maroko PB, Sobel BE. Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog. Cardiovasc Res,1972,6(5) :490-499.
-
10Kleber AG. ST-segment elevation in the electrocardiogram: a sign of myecaniial iechemia. Cardiovasc Res, 2000,45(1) :111-118.
共引文献2072
-
1毕颖斐,王贤良,赵志强,侯雅竹,毛静远,张伯礼.冠心病中医证候地域性特征的临床流行病学调查[J].中医杂志,2020,61(5):418-422. 被引量：65
-
2金梦雨,俞赟丰,兰晓栋,罗晓欣,简维雄.养心通脉方治疗冠状动脉粥样硬化性心脏病心绞痛的Meta分析和试验序贯分析[J].中医临床研究,2021,13(34):132-136. 被引量：2
-
3黄铭,韩冬,昌震.柴胡疏肝散合血府逐瘀汤加减对冠心病稳定型心绞痛的疗效及对负面情绪的影响[J].中药材,2022,45(12):3007-3011. 被引量：8
-
4解晓青,李洁,解品启.温阳益气方对冠心病心绞痛患者心功能及血液流变学的影响[J].中药材,2022,45(8):1986-1989. 被引量：1
-
5张海荣,苏和,张瑞芬,王智业.蒙药当贡-3胶囊治疗冠心病稳定型心绞痛的临床观察[J].中国民族医药杂志,2021,27(10):15-17. 被引量：2
-
6徐亚军.瓜蒌皮注射液治疗冠心病稳定型心绞痛合并2型糖尿病102例疗效观察[J].智慧健康,2021,7(21):128-131.
-
7李建军.增强型体外反搏对冠心病稳定型心绞痛患者血流动力学及心功能的影响[J].慢性病学杂志,2020(9):1382-1383. 被引量：2
-
8王来强.芪蛭三七汤治疗冠心病稳定型心绞痛气虚血瘀症的疗效[J].心理月刊,2021(12):80-81. 被引量：1
-
9褚桂克,黄云义.活血养阴汤治疗糖尿病合并动脉粥样硬化的临床疗效观察[J].实用中医内科杂志,2023,37(1):126-129. 被引量：1
-
10许园园,陈玉凤.硝普钠干预治疗老年缺血性心力衰竭对血浆硫化氢水平影响[J].社区医学杂志,2020(7):513-516.
-
1徐凤珍,高福生,郑翠霞,王爱华,刘玉珠.慢性阻塞性肺病患者营养状态与运动通气耗氧[J].蚌埠医学院学报,1998,23(2):74-75. 被引量：14
-
2马向阳.1,6—二磷酸果糖与复方丹参合用治疗冠心病的体会[J].吉林医学信息,2006,0(Z2):5-6.
-
3吕洪博.无创通气治疗COPD合并呼吸衰竭40例临床观察[J].当代医学,2009,15(9):47-47. 被引量：8
-
4朱秀龙,张灿,孙喜文,陈炎,黄猛.阿托伐他汀对ST段抬高心肌梗死患者血清C反应蛋白、IL-6水平的影响[J].细胞与分子免疫学杂志,2009,25(6):545-546. 被引量：1
-
5曹建存.无创呼吸机治疗慢性阻塞性肺疾病合并呼吸衰竭的疗效探讨[J].数理医药学杂志,2017,30(2):181-182. 被引量：8
-
6马元良,袁晋青.尿酸水平对心肌梗死发病及其预后影响研究现状[J].中国分子心脏病学杂志,2015,15(5):1477-1480.
-
7胡佳,丁晓娟.Rho激酶抑制剂对冠心病不稳定型心绞痛的疗效[J].实用医学杂志,2008,24(21):3753-3754. 被引量：7
-
8孙丽.不同剂量氯吡格雷辅助治疗急性ST段抬高心肌梗死的量效关系及安全性[J].现代中西医结合杂志,2013,22(28):3134-3136. 被引量：5
-
9汤立洁,杨艳明,陈媛.麝香保心丸联合阿托伐他汀钙治疗冠心病心绞痛60例[J].陕西中医,2014,35(5):556-557. 被引量：5
-
10姚林艳.无创呼吸机治疗呼吸衰竭患者的临床效果[J].医疗装备,2017,30(1):144-145.
